There is provided a single preparation which directly decreases both of the post prandial blood glucose level and the fasting blood glucose level close to normal levels, by release-sustaining a drug capable of decreasing the post prandial blood glucose level of diabetic patients close to the normal level, or mixing a controlled release drug capable of decreasing the post prandial blood glucose level close to the normal level with an immediate release drug. It is particularly preferable that the drug capable of decreasing the post prandial blood glucose level close to the normal level is nateglinide.

 
Web www.patentalert.com

< Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2

< Hydrogel particle formulation

> Benzimidazoles that are useful in treating male sexual dysfunction

> Electrophotographic toner and image-forming system

~ 00250